By Tarun Sai Lomte Reviewed by Susha Cheriyedath, M.Sc. Apr 21 2026 A new study shows that some of the deadliest cancers in the US receive far less NIH funding relative to their toll, raising urgent questions about how research dollars are allocated and whether current priorities match clinical need. Research letter: Incidence, Mortality, and Federal Research Funding by Cancer Type in the US . Image Credit: Kateryna Kon / Shutterstock In a recent study published in  JAMA Network Open ,